Sciensus Pharma Services Limited - Strategic SWOT Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI's, and Recent Trends
Company Report I 2025-06-20 I 70 Pages I Quaintel Research
Report Summary
Sciensus Pharma Services Limited - Strategic SWOT Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI's, and Recent Trends is a comprehensive and easily accessible overview of Sciensus Pharma Services Limited 's business operations. It provides a detailed analysis of the company's strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Sciensus Pharma Services Limited including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Sciensus Pharma Services Limited's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of Sciensus Pharma Services Limited's overall strategic standing and supports informed decision-making and strategic planning.
Finally, the report includes recent news and deal activities undertaken by Sciensus Pharma Services Limited enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Sciensus Pharma Services Limited, formerly known as Healthcare at Home, is a leading pharmaceutical supplier and home healthcare provider based in Burton on Trent, UK. Established in 1992 by founder and former chairman Charles Walsh, the company has grown to employ around 1,700 people and serve over 230,000 patients annually across the UK.The company's core services include pharmaceutical supply and distribution, home healthcare services, and specialty pharmacy services.
Sciensus supplies a wide range of pharmaceuticals to patients, healthcare providers, and pharmaceutical companies, working with every NHS trust in the UK to ensure patients have access to the medications they need. The company also specializes in providing in-home care for patients with long-term conditions, rare diseases, and cancer, with a team of healthcare professionals delivering treatments and therapies directly to patients' homes, improving access and convenience.
Additionally, Sciensus offers bespoke services to connect pharmaceutical companies, insurers, and healthcare professionals with patients who require rare, orphan, or hard-to-access medications, including global distribution and patient support programs.However, in 2023, Sciensus faced regulatory issues, including a partial suspension of its license by the MHRA following an incident involving unlicensed chemotherapy treatments. The company was also given a warning by the Parliamentary and Health Service Ombudsman regarding its complaints handling process. Despite these challenges, Sciensus remains a significant player in the UK's healthcare landscape, providing essential services to thousands of patients.
Sciensus Pharma Services Limited in the News:-
- 13-May-2025 - Sciensus achieves 95% patient satisfaction and record NPS
- 23-Apr-2025 - Sciensus achieves ISO 14001 accreditation
- 23-Apr-2025 - Sciensus announces appointment of Kerry Utton as it continues to strengthen its pharma capabilities
- 02-Apr-2025 - Sciensus Easter 2025 bank holiday opening hours
- 28-Feb-2025 - Sciensus' new depot allows for increased capacity and improved environmental and social impact
Scope
- Tactical Analysis:- Various strategic frameworks to gain insights into a Sciensus Pharma Services Limited's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the Sciensus Pharma Services Limited's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Company Fundamentals:- These fundamentals offer valuable insights into the Sciensus Pharma Services Limited's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the Sciensus Pharma Services Limited's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
- Comprehensive Understanding of the Sciensus Pharma Services Limited's internal and external factors through SWOT analysis and Corporate Strategy.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Sciensus Pharma Services Limited:
- Sciensus Pharma Services Limited PESTLE Analysis
- Sciensus Pharma Services Limited Value Chain Analysis
- Sciensus Pharma Services Limited Porter's Five Forces Analysis
- Sciensus Pharma Services Limited VRIO Analysis
- Sciensus Pharma Services Limited BCG Analysis
- Sciensus Pharma Services Limited Segmentation, Targeting and Positioning (STP) Analysis
- Sciensus Pharma Services Limited Ansoff Matrix Analysis
Table of Contents
Table of Contents 2
Tables 5
Charts 6
Sciensus Pharma Services Limited - Key Company Facts 7
Sciensus Pharma Services Limited - Company Description 8
Sciensus Pharma Services Limited - Top Executives 9
Sciensus Pharma Services Limited - Head Office & Locations 10
Head Office - Country 10
Sciensus Pharma Services Limited - Products and Services 11
Services 11
Sciensus Pharma Services Limited - Corporate Strategy 13
Sciensus Pharma Services Limited - Business Description 16
Homecare Services 16
Clinical Services 17
Supply Chain Solutions 17
Consulting and Support Services 18
Sciensus Pharma Services Limited - ESG Spotlight 19
Environment 19
Social 19
Corporate Governance 20
Sciensus Pharma Services Limited - SWOT Analysis 21
Overview 21
Strengths 23
Weaknesses 25
Opportunities 27
Threats 29
Competing Players 30
Snapshot of Competing Players 31
Health Catalyst Inc. 31
Key Company Facts 31
Company Description 31
Key Financials 32
Share Price Trend - Jan-2024 to Jun-2025 (Average Share Closing Price) 32
Key Financial Ratio Analysis 37
NextGen Healthcare Inc. 38
Key Company Facts 38
Company Description 38
Veeva Systems Inc 39
Key Company Facts 39
Company Description 39
Key Financials 40
Share Price Trend - May-2024 to Jun-2025 (Average Share Closing Price) 40
Key Financial Ratio Analysis 45
athenahealth Inc 46
Key Company Facts 46
Company Description 46
Phreesia Inc 47
Key Company Facts 47
Company Description 47
Key Financials 48
Share Price Trend - Jan-2024 to Jun-2025 (Average Share Closing Price) 48
Key Financial Ratio Analysis 53
Sciensus Pharma Services Limited - In the News 54
13-May-2025- Sciensus achieves 95% patient satisfaction and record NPS 54
23-Apr-2025- Sciensus achieves ISO 14001 accreditation 55
23-Apr-2025- Sciensus announces appointment of Kerry Utton as it continues to strengthen its pharma capabilities 57
02-Apr-2025- Sciensus Easter 2025 bank holiday opening hours 58
28-Feb-2025- Sciensus' new depot allows for increased capacity and improved environmental and social impact 59
20-Jun-2024- Personalised Vaccines and Cancer Treatment 60
10-May-2024- Sciensus hosts a panel at the World Orphan Drug Congress 2024 61
08-May-2024- Sciensus partners with Observia to improve medication adherence through behavioural insights 63
29-Feb-2024- Sciensus partners with ITN and Genetic Alliance UK for Rare Disease Day 65
28-Feb-2024- Sciensus to integrate pathology test results into iQemo 66
Appendix 67
Definitions 67
SWOT Analysis 67
PESTLE Analysis 67
Value Chain Analysis 67
ESG Spotlight 67
Research Methodology 68
Disclaimer 69
Contact Us 69
Tables
Table 1: Sciensus Pharma Services Limited - Company Facts
Table 2: Sciensus Pharma Services Limited - Digital Presence
Table 3: Sciensus Pharma Services Limited - Top Executives
Table 4: Sciensus Pharma Services Limited - Services
Table 5: Sciensus Pharma Services Limited -Competing Players
Table 6: Competing Players - Health Catalyst Inc. - Key Company Facts
Table 7: Health Catalyst Inc. - Share Price Trend - Jan-2024 to Jun-2025
Table 8: Competing Players - Health Catalyst Inc. - Profit and Loss Statement
Table 9: Health Catalyst Inc. - Balance Sheet 2021-2024
Table 10: Health Catalyst Inc. - Cash Flow Statement 2021-2024
Table 11: Health Catalyst Inc. - Ratio Analysis - 2020-2023
Table 12: Competing Players - NextGen Healthcare Inc. - Key Company Facts
Table 13: Competing Players - Veeva Systems Inc - Key Company Facts
Table 14: Veeva Systems Inc - Share Price Trend - May-2024 to Jun-2025
Table 15: Competing Players - Veeva Systems Inc - Profit and Loss Statement
Table 16: Veeva Systems Inc - Balance Sheet 2021-2024
Table 17: Veeva Systems Inc - Cash Flow Statement 2021-2024
Table 18: Veeva Systems Inc - Ratio Analysis - 2021-2024
Table 19: Competing Players - athenahealth Inc - Key Company Facts
Table 20: Competing Players - Phreesia Inc - Key Company Facts
Table 21: Phreesia Inc - Share Price Trend - Jan-2024 to Jun-2025
Table 22: Competing Players - Phreesia Inc - Profit and Loss Statement
Table 23: Phreesia Inc - Balance Sheet 2021-2024
Table 24: Phreesia Inc - Cash Flow Statement 2021-2024
Table 25: Phreesia Inc - Ratio Analysis - 2021-2024
Charts
Figure 1: Sciensus Pharma Services Limited - SWOT Analysis 22
Figure 2: Health Catalyst Inc. - Average Share Price Trend -Jan-2024 to Jun-2025 33
Figure 3: Health Catalyst Inc. - Profit and Loss Statement - 2021-2024 34
Figure 4: Health Catalyst Inc. - Balance Sheet - 2021-2024 35
Figure 5: Health Catalyst Inc. - Cash Flow Statement 2021-2024 36
Figure 6: Veeva Systems Inc - Average Share Price Trend -May-2024 to Jun-2025 41
Figure 7: Veeva Systems Inc - Profit and Loss Statement - 2021-2024 42
Figure 8: Veeva Systems Inc - Balance Sheet - 2021-2024 43
Figure 9: Veeva Systems Inc - Cash Flow Statement 2021-2024 44
Figure 10: Phreesia Inc - Average Share Price Trend -Jan-2024 to Jun-2025 49
Figure 11: Phreesia Inc - Profit and Loss Statement - 2021-2024 50
Figure 12: Phreesia Inc - Balance Sheet - 2021-2024 51
Figure 13: Phreesia Inc - Cash Flow Statement 2021-2024 52
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.